HADV OTC
Health Advance Inc.
1W: +0.0%
1M: -33.3%
3M: +0.0%
YTD: -41.2%
1Y: -55.6%
3Y: -96.1%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±14.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$65K
+0.0% ▲
Net Income
-$87K
+0.0% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$65K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $20K | $7K | $0 | $0 | $0 |
| YoY Growth | +0.0% | -67.5% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $20K | $7K | $0 | $0 | $0 |
| Gross Margin | 100.0% | 100.0% | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $42K | $133K | $266K | $48K | $65K |
| Operating Expenses | $42K | $133K | $266K | $48K | $65K |
| Operating Income | -$22K | -$126K | -$266K | -$48K | -$65K |
| Operating Margin | -109.7% | -1940.7% | — | — | — |
| Interest Expense | $21 | $652 | $852 | $1K | $24K |
| Income Before Tax | $17K | -$131K | -$270K | -$49K | -$87K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $17K | -$131K | -$270K | -$49K | -$87K |
| Net Margin | 84.7% | -2007.4% | — | — | — |
| EPS (Diluted) | $0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 |
| EBITDA | $254K | $98K | -$101K | -$48K | -$65K |
| Shares Outstanding | 161M | 161M | 186M | 186M | 1.28B |